Perceptive Advisors as of June 30, 2025
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 84 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Verona Pharma Sponsored Ads (VRNA) | 19.3 | $521M | 5.5M | 94.58 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 6.2 | $166M | 964k | 172.60 | |
| Arcellx Common Stock (ACLX) | 6.0 | $163M | 2.5M | 65.85 | |
| Rhythm Pharmaceuticals (RYTM) | 5.7 | $153M | 2.4M | 63.19 | |
| Nuvalent Inc-a (NUVL) | 3.9 | $105M | 1.4M | 76.30 | |
| CryoLife (AORT) | 3.2 | $87M | 2.8M | 31.10 | |
| Meiragtx Holdings (MGTX) | 3.0 | $82M | 13M | 6.51 | |
| Insmed Com Par $.01 (INSM) | 2.4 | $65M | 650k | 100.64 | |
| Edgewise Therapeutics (EWTX) | 2.3 | $61M | 4.6M | 13.11 | |
| Protagonist Therapeutics (PTGX) | 2.2 | $59M | 1.1M | 55.27 | |
| Solid Biosciences Com New (SLDB) | 2.1 | $58M | 12M | 4.87 | |
| Apogee Therapeutics (APGE) | 1.9 | $51M | 1.2M | 43.43 | |
| Amylyx Pharmaceuticals (AMLX) | 1.9 | $51M | 7.9M | 6.41 | |
| Immatics SHS (IMTX) | 1.9 | $51M | 9.4M | 5.38 | |
| Akero Therapeutics (AKRO) | 1.8 | $49M | 916k | 53.36 | |
| Omada Health (OMDA) | 1.6 | $44M | 2.4M | 18.30 | |
| Amicus Therapeutics (FOLD) | 1.6 | $43M | 7.4M | 5.73 | |
| Roivant Sciences SHS (ROIV) | 1.4 | $38M | 3.3M | 11.27 | |
| Merus N V (MRUS) | 1.4 | $37M | 708k | 52.60 | |
| Soleno Therapeutics (SLNO) | 1.3 | $36M | 430k | 83.78 | |
| Astria Therapeutics (ATXS) | 1.3 | $35M | 6.5M | 5.36 | |
| Immunovant (IMVT) | 1.3 | $34M | 2.1M | 16.00 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $32M | 255k | 125.69 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.2 | $32M | 753k | 42.05 | |
| Boston Scientific Corporation (BSX) | 1.1 | $30M | 280k | 107.41 | |
| Caris Life Sciences (CAI) | 1.1 | $29M | 1.1M | 26.72 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 0.9 | $25M | 300k | 82.93 | |
| Intuitive Surgical Com New (ISRG) | 0.9 | $25M | 45k | 543.41 | |
| Adma Biologics (ADMA) | 0.9 | $24M | 1.3M | 18.21 | |
| Beta Bionics Com New (BBNX) | 0.9 | $23M | 1.6M | 14.56 | |
| Spyre Therapeutics Com New (SYRE) | 0.8 | $23M | 1.5M | 14.97 | |
| Evolus (EOLS) | 0.8 | $23M | 2.5M | 9.21 | |
| Celcuity (CELC) | 0.8 | $22M | 1.6M | 13.35 | |
| Dyne Therapeutics (DYN) | 0.8 | $21M | 2.2M | 9.52 | |
| Sionna Therapeutics (SION) | 0.8 | $21M | 1.2M | 17.35 | |
| Axsome Therapeutics (AXSM) | 0.8 | $21M | 199k | 104.39 | |
| Repligen Corporation (RGEN) | 0.8 | $21M | 166k | 124.38 | |
| Insulet Corporation (PODD) | 0.7 | $19M | 60k | 314.18 | |
| Outset Medical (OM) | 0.6 | $16M | 833k | 19.21 | |
| Zymeworks Del (ZYME) | 0.6 | $16M | 1.3M | 12.55 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $16M | 7.0M | 2.27 | |
| Aldeyra Therapeutics (ALDX) | 0.6 | $16M | 4.1M | 3.83 | |
| Charles River Laboratories (CRL) | 0.6 | $15M | 100k | 151.73 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $15M | 1.1M | 13.14 | |
| Inhibrx Biosciences (INBX) | 0.5 | $14M | 978k | 14.27 | |
| Adagio Med Hldgs (ADGM) | 0.5 | $13M | 9.9M | 1.30 | |
| Nurix Therapeutics (NRIX) | 0.5 | $13M | 1.1M | 11.39 | |
| Travere Therapeutics (TVTX) | 0.5 | $12M | 834k | 14.80 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.5 | $12M | 4.6M | 2.68 | |
| Bright Minds Biosciences Com New (DRUG) | 0.4 | $11M | 421k | 26.11 | |
| Inhibikase Therapeutics Com New (IKT) | 0.4 | $11M | 5.4M | 1.95 | |
| Viking Therapeutics (VKTX) | 0.4 | $10M | 381k | 26.50 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $9.8M | 270k | 36.36 | |
| Kymera Therapeutics (KYMR) | 0.3 | $9.2M | 210k | 43.64 | |
| Nautilus Biotechnology (NAUT) | 0.3 | $9.1M | 13M | 0.72 | |
| Penumbra (PEN) | 0.3 | $8.4M | 33k | 256.63 | |
| Capricor Therapeutics Com New Call Option (CAPR) | 0.3 | $7.4M | 750k | 9.93 | |
| Crescent Biopharma (CBIO) | 0.3 | $7.3M | 454k | 16.14 | |
| Aquestive Therapeutics (AQST) | 0.3 | $7.3M | 2.2M | 3.31 | |
| Janux Therapeutics (JANX) | 0.3 | $6.8M | 293k | 23.10 | |
| Anteris Technologies Global (AVR) | 0.2 | $6.5M | 1.7M | 3.79 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $6.3M | 201k | 31.30 | |
| Miragen Therapeutics (VRDN) | 0.2 | $6.3M | 448k | 13.98 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $5.8M | 1.4M | 4.00 | |
| Septerna (SEPN) | 0.2 | $5.7M | 542k | 10.57 | |
| Globus Med Cl A (GMED) | 0.2 | $5.2M | 89k | 59.02 | |
| Envveno Medical (NVNO) | 0.2 | $5.1M | 1.3M | 3.99 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.2 | $4.2M | 398k | 10.62 | |
| Ocuphire Pharma (IRD) | 0.2 | $4.1M | 4.3M | 0.94 | |
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $2.8M | 700k | 3.97 | |
| Lyra Therapeutics Com New (LYRA) | 0.1 | $2.3M | 255k | 8.96 | |
| Scpharmaceuticals (SCPH) | 0.1 | $1.9M | 500k | 3.81 | |
| Athira Pharma (ATHA) | 0.1 | $1.6M | 5.4M | 0.30 | |
| Rapt Therapeutics Com New (RAPT) | 0.1 | $1.5M | 184k | 8.00 | |
| Trinity Biotech Spons Adr New (TRIB) | 0.0 | $1.2M | 1.8M | 0.65 | |
| Forte Biosciences Com New (FBRX) | 0.0 | $882k | 68k | 12.93 | |
| Avalo Therapeutics Com New (AVTX) | 0.0 | $697k | 140k | 4.99 | |
| Biodesix (BDSX) | 0.0 | $613k | 2.2M | 0.28 | |
| Lexeo Therapeutics (LXEO) | 0.0 | $562k | 140k | 4.02 | |
| Apyx Medical Corporation (APYX) | 0.0 | $338k | 150k | 2.25 | |
| Kala Bio Com New (KALA) | 0.0 | $263k | 55k | 4.76 | |
| Ensysce Biosciences Com New (ENSC) | 0.0 | $193k | 87k | 2.23 | |
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $66k | 250k | 0.26 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.0k | 167k | 0.02 |
